Health Condition 1: G00-G99- Diseases of the nervous system
Conditions
Interventions
None listed
Sponsors
Non funded project
Eligibility
Inclusion criteria
Inclusion criteria: All patients admitted to the ICU in a pre-specified week
Exclusion criteria
Exclusion criteria: Patients younger than 18 years old.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of transfused units of red blood cells concentrates, platelet concentrates, plasma, cryoprecipitate when available and products that are not blood components but that derived from blood and that include coagulations factors such as prothrombin complex, fibrinogen or tranexamic acid per patient.Timepoint: -Baseline -After transfusion of blood components | — |
Secondary
| Measure | Time frame |
|---|---|
| i) Mortality and length of stay in the ICU ii) Differences of transfusion regimes between world regions iii) Differences of transfusion practices between different patient subgroups Timepoint: 1. Before and after blood transfusion 2.At 28 days | — |
Countries
Austria, Bangladesh, Belgium, Brazil, Canada, Czech Republic, Ecuador, Egypt, France, Germany, Greece, Hungary, India, Iran (Islamic Republic of), Iraq, Ireland, Italy, Libyan Arab Jamahiriya, Mexico, Netherlands, Poland, Qatar, Romania, Saudi Arabia, Serbia, Slovenia, South Africa, Spain, Sri Lanka, Sudan, Swaziland, Turkey, United Arab Emirates, United States of America
Contacts
Public ContactGopalakrishna K N
National Institute of Mental Health and Neurosciences, Bangalore
Outcome results
None listed